With 0.53 million shares changed hands, the volume of the stock remained lighter than its average volume of 1.1 million shares. The 52-week range on VIR shows that it touched its highest point at $27.48 and its lowest point at $7.72 during that stretch. It currently has a 1-year price target of $29.50. Beta for the stock currently stands at 0.42.
Price Performance and Earnings:
Stock performance is one of the indicators that investors use to determine whether they will profit from a stock. The price performance of VIR was down-trending over the past week, with a drop of -7.80%, but this was down by -14.47% over a month. Three-month performance dropped to -9.06% while six-month performance rose 4.59%. The stock lost -59.93% in the past year, while it has lost -7.16% so far this year. A look at the trailing 12-month EPS for VIR yields -4.59 with Next year EPS estimates of -3.97. For the next quarter, that number is -1.05. This implies an EPS growth rate of 10.92% for this year and 2.98% for next year. EPS is expected to grow by 7.00% annually over the next five years; however, over the past five years, the company experienced an annual growth rate of -34.12%.
Float and Shares Shorts:
At present, 134.78 million VIR shares are outstanding with a float of 88.08 million shares on hand for trading. On Mar 15, 2024, short shares totaled 5.43 million, which was 4.02% higher than short shares on Feb 15, 2024. In addition to Dr. Ann M. Hanly Ph.D. as the firm’s Executive VP & Chief Technology Officer, Dr. Phillip Pang M.D., Ph.D. serves as its Executive VP & Chief Medical Officer.
Institutional Ownership:
Through their ownership of 76.30% of VIR’s outstanding shares, institutional investors have majority control over the company.
Analysts Ratings:
Reading analyst opinions is an effective way to decide where to invest, and there are several opinions available for VIR since 0 analysts follow the stock currently. In the same way, a target price assigned to a stock can also reveal much about its potential.
Dividends & Yield:
In terms of dividends, VIR has a current ratio of $––, which is $–– over the trailing 12-months, while a dividend of $–– is likely to be paid on average over the next five years. Dividend yield is another indicator that appeals to many investors, and VIR currently yields $0.00. In the past year, VIR’s dividend yield has been $0.00, but when looking at the stock over the past five years, its yield has been $–. Accordingly, VIR has a current buyback yield of $0.00. This was $0.00 for the TTM, and it was $– for the past five years.